These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8329662)

  • 21. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 22. Citrate and renal calculi: new insights and future directions.
    Pak CY
    Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in-vivo effect of sodium-potassium citrate on the crystal growth rate of calcium oxalate and other parameters in human urine.
    Achilles W; Schulze D; Schalk C; Rodeck G
    Urol Res; 1990; 18(1):1-6. PubMed ID: 2316065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
    Berg C; Larsson L; Tiselius HG
    J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of orange juice consumption on urinary stone risk factors.
    Wabner CL; Pak CY
    J Urol; 1993 Jun; 149(6):1405-8. PubMed ID: 8501777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
    Pylypchuk G; Ehrig U; Wilson DR
    Can Med Assoc J; 1979 Mar; 120(6):658-65. PubMed ID: 436047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary factors of kidney stone formation in patients with Crohn's disease.
    Böhles H; Beifuss OJ; Brandl U; Pichl J; Akçetin Z; Demling L
    Klin Wochenschr; 1988 Feb; 66(3):87-91. PubMed ID: 3352194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: Potassium Citrate Decreases Urine Calcium Excretion in Patients with Hypocitraturic Calcium Oxalate Nephrolithiasis.
    Assimos DG
    J Urol; 2016 Sep; 196(3):775-6. PubMed ID: 27597074
    [No Abstract]   [Full Text] [Related]  

  • 35. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting.
    Nicar MJ; Hsu MC; Fetner C
    Clin Ther; 1986; 8(2):219-25. PubMed ID: 3698069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):918-31. PubMed ID: 3051946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
    Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
    J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of citrate complexes in preventing urolithiasis.
    Ashby RA; Sleet RJ
    Clin Chim Acta; 1992 Sep; 210(3):157-65. PubMed ID: 1468138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
    Nicar MJ; Peterson R; Pak CY
    J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A urinary calcium-citrate index for the evaluation of nephrolithiasis.
    Parks JH; Coe FL
    Kidney Int; 1986 Jul; 30(1):85-90. PubMed ID: 3747347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.